KYORIN Pharmaceutical Co.,Ltd. Financial Overview
KYORIN Pharmaceutical Co.,Ltd.'s market cap is currently ¥79.12B. The company's EPS TTM is ¥-10.56; its P/E ratio is 9.26; and it has a dividend yield of 3.46%. KYORIN Pharmaceutical Co.,Ltd. is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
